A B S T R A C T Lactic acid represents a major exogenous nutrient for the developing fetal lamb in utero. Our study was undertaken (a) to quantitate the net consumption of lactate by the fetus, (b) to quantitate the net lactate production and metabolism by the placenta, and (c) to compare the net fetal lactate consumption with fetal lactate use, measured simultaneously with radioactive tracers. 14 pregnant sheep were prepared with catheters in the maternal femoral artery and uterine vein and in the fetal aorta and umbilical vein. By simultaneous application of the Fick principle to the uterine and umbilical circulations, placental glucose consumption and placental lactate production were rapid, averaging 39.8±5.1 and 11.8±0.7 mg. min-'. Net lactate umbilical uptake averaged 1.95±0.16 mg-' kg-' min-'. During infusion of L-[14C(U)]lactate, fetal lactate turnover was much more rapid, averaging 6.5±0.8 mg* kg-' * min-1, and lactate utilization within the anatomic fetus was 5.9±0.7 mg* kg-l min-'. During infusion of tracer glucose, endogenous fetal lactate production from glucose and nonglucose substrates averaged 3.0 and 1.5 mg * kg-l * min-1, respectively. The present studies have quantitated under well oxygenated, steady-state conditions, the rapid placental metabolism and production of lactate, the net fetal consumption of lactate, and the rapid endogenous fetal lactate production from glucose and nonglucose substrates.
INTRODUCTION
Lactate, glucose, and amino acids are the major exogenous nutrients consumed by the fetal lamb, providing calories, carbon, and nitrogen for fetal growth and oxidative metabolism (1, 2). That amino acids and glucose are major exogenous nutrients for the fetus is not surprising, given the net accretion of protein durReceived for publication 31 March 1981 and in revised form 23 February 1982. ing fetal growth and the apparent requirement for glucose by fetal organs, most notably brain (3) . However, the physiologic significance of a large exogenous supply of lactate has received comparatively little attention (4, 5) .
Earlier reports in several species had noted that the concentration of lactate in fetal blood is normally higher than in the mother, and concluded that fetal metabolism may be anaerobic (6) (7) (8) . More recent studies in the chronically catheterized fetal lamb and calf (4, 5, 9) , while confirming a higher fetal than maternal lactate concentration, have noted that the lactate concentration is higher in the fetal umbilical vein than in the fetal artery. Furthermore, the lactate concentration was noted to be higher in the uterine vein than in the maternal artery. Such observations imply net production of lactate by the uteroplacenta, with net consumption of this lactate both in the fetus and in the mother.
Our study was designed to quantitate separately the metabolism of lactate by the fetus and by the uteroplacenta, under in vivo steady-state conditions. Simultaneous measurements of lactate concentrations and uterine and umbilical blood flows were used to calculate net substrate fluxes into the umbilical and uterine circulations. Fetal lactate use was measured by tracer infusion into the fetus, allowing simultaneous estimation of endogenous fetal lactate production. kg-') and pontocaine spinal anesthesia (6 mg in 10% glucose). Polyvinyl catheters were placed in the fetal umbilical vein, fetal pedal artery, fetal pedal vein, maternal femoral artery, and maternal uterine vein as described (10, 11) . The fetal pedal arterial catheter was advanced into the descending aorta to sample the blood supplying the umbilical artery. The catheter in the fetal umbilical vein was positioned before the portal sinus to sample the blood flowing through the common umbilical vein. Fetal pedal venous catheters were placed for infusions. These catheters were advanced to the level of the femoral vein. Animals were allowed to recover from surgery for at least 6 d, and free access to water and food (oats, alfalfa pellets, and hay) was permitted except as noted. Food intake of each animal was qualitatively monitored by weighing the feed and estimating the consumption of hay.
The study protocol compared measurements of fluxes of lactate, glucose, and oxygen with simultaneous measurements of lactate metabolism made with 3H and 14C tracers. A primed, constant infusion technique was used for both antipyrine and tracer infusions. A priming dose of antipyrine and of tracer was given through a fetal pedal vein, followed by constant infusion of antipyrine and tracer by pump, into the pedal vein. After a 60-min equilibration period whole blood samples were taken simultaneously from the fetal artery, umbilical vein, maternal artery, and maternal uterine vein at times of 60, 90, 120, and 150 min after the beginning of the infusions. Blood samples were analyzed for concentrations of glucose, lactate, oxygen, and antipyrine, and for specific activities of glucose, lactate, and CO2.
Tracer infusions. 8 (11) was labeled at carbon "X" and "Y", as detailed in Table III (16) . Using these values, the priming dose of tracer and the constant tracer infusion rate were chosen to obtain steady-state conditions rapidly during the infusion periods. In a typical experiment, the lactate specific activities in each vessel at each time point were within 5% of the mean specific activity for that vessel over the study period. Additionally, the relationships between the specific activities of lactate in the vessels sampled remained constant over the infusion periods. Analytical methods. Whole blood was collected in iced syringes and immediately deproteinized for glucose analysis using a glucose oxidase method (12) . Whole blood was collected in syringes frozen in ice, immediately deproteinized in perchloric acid, and assayed for lactate concentration using a fluorometric method (13) . Whole blood was collected in iced, NaF-coated capillary tubes, and analyzed immediately for 02 content using a Lex-02-Con (Lexington Instruments Corp., Waltham, MA). CO2 was measured with a van Slyke apparatus. Antipyrine was measured in whole blood with a Technicon Auto Analyzer (Technicon Instruments Corp., Tarrytown, NY) (14) .
Specific activities of glucose were measured as described (11) . Lactate specific activity was determined on plasma, using the following modification of the method of Rognstead and Katz (17) . A Dowex 1 X 8 (chloride) column (3 X 70 mm) was washed sequentially with 4 vol 1 N NaOH and 6 vol 1 N NaF, converting it to fluoride form. Blood was collected in iced syringes coated with EDTA and NaF, centrifuged, and immediately separated into plasma and cellular fractions. A volume of 200 ul plasma was then applied directly to the column without deproteinization. A wash of 2 vol 1 N NaF and 6 vol distilled demineralized water removed >99.9% of the protein and neutral compounds, including glucose and alanine. The column retained >98% of the lactate, which was then removed with 4 vol sequential washes of 0.3 N acetic acid and 2 N acetic acid. Approximately 85% of the lactate was recovered in the 2 N acetic acid fraction.
Two-dimensional paper chromatography (18) According to this nomenclature, the capital letters L, 0, and G represent lactate, oxygen, and glucose, respectively. The superscripts C, D, and S represent respectively "concentration" in mg -ml-', "dpm" in dpm * ml-', and specific activity in dpm -mg-'. The (Table II) , resulting in a lower net uterine glucose uptake. Net uterine oxygen consumption was not significantly different in the two subgroups.
Net fetal substrate fluxes. Fetal arterial and umbilical venous catheters were maintained chronically in 14 fetuses. Concentrations of lactate, glucose, and oxygen were measured in blood samples from these vessels, and the net flux of substrates entering the fetus was calculated by the Fick principle (Table II) .
Each of the 14 fetuses was well oxygenated, with umbilical venous oxygen concentrations averaging 5.23±0.16 mM. Net fetal oxygen consumption was 0.299±0.020 mmol kg-'. Fetal arterial and venous lactate concentrations were each higher than the maternal levels (P < 0.001, paired) and umbilical venous lactate concentration was consistently higher than the fetal arterial concentration (P < 0.001, paired; Fig. 1 4. Net fetal glucose uptake = Qf(Gc -Gc) 5 . Net uterine glucose loss = QF(Gc-Gc) 6 . Net placental glucose consumption = (Eq. 5) -(Eq. 4) 6 X (Gc -Gc) were maintained chronically in both the uterine and umbilical circulations, oxygen consumption by the uteroplacenta was extremely rapid, averaging 0.98±0.13 mmol -min-', or -45% of the oxygen leaving the maternal circulation.
Glucose consumption by the uteroplacenta was also rapid. For the seven normoglycemic animals, glucose consumption averaged 39.8±5.1 mg min-', or 78±2.9% of the glucose leaving the mother. The uteroplacenta also produced large amounts of lactate, of which 4.97±0.67 mg -min-' were discharged into the maternal circulation, and 6.34±0.70 mg. min-' into the fetal umbilical circulation. In the group characterized by low maternal arterial glucose concentration, consumption of glucose and production of lactate by the uteroplacenta were reduced -35%.
Fetal tween fetal lactate utilization and fetal glucose uptake (r = 0.89, P < 0.01, Fig. 3 ) and between fetal lactate utilization and umbilical venous glucose concentration (r = 0.84, P < 0.025).
In each of the six animals, fetal lactate utilization exceeded the simultaneously measured umbilical lactate uptake. This difference represents endogenous fetal lactate production, and averaged 4.45±0.67 mg. kg-1' min-'. Fetal lactate production also correlated significantly with umbilical glucose uptake (r = 0.85, P < 0.025).
Fetal glucose specific activity averaged 3.3±1.1% of the fetal lactate specific activity during infusion of L-[14C(U)]lactate and was higher than maternal glucose specific activity. We conclude therefore that a small but detectable quantity of labeled glucose was produced from lactate within the fetus.
Samples were obtained from both uterine venous and maternal arterial catheters during fetal infusion of L-[14C(U)]lactate in five animals. In each of these animals, both lactate specific activity and dpmlactate. ml-' were higher in the uterine venous sample compared to the maternal arterial sample. Net were infused into the fetus the specific activity of lactate in the umbilical vein was lower than in the umbilical artery (P < 0.01, paired). Two physiologically important conclusions can be inferred from this observation. The first is that the higher fetal arterial lactate specific activity can be maintained only if the fetus synthesizes lactate from the labeled tracer, glucose. The second conclusion is that the placenta infuses into the fetus lactate derived from unlabeled precursors. These conclusions follow from the assumption that unlabeled tracee lactate and labeled tracer lactate are metabolized identically. In the absence of isotope effects, removal of lactate from a well-mixed pool consumes tracer and tracee lactate proportionally, so that consistently maintained differences in specific activity at different sampling sites must reflect new entry of tracer or tracee at some anatomic site between the sampling sites. Qualitatively, then, the observed concentrations of labeled and unlabeled lactate in the umbilical circuLactate Turnover and Uptake in the Fetal Lamb 185 lation during fetal tracer glucose infusion require that the fetus produce lactate endogenously. Mathematically, further description of this fetal lactate production can be made, as described in the Appendix. When tracer glucose is infused the term LPRcin may be calculated by Eq. 18. This term represents the minimum production of lactate from glucose which must occur within the fetus in order to account for measured concentration differences. Secondly, a constant "k1" may be derived, which partitions any additional endogenous fetal lactate production between glucose and nonglucose substrates. Values of LPR',U, were calculated in experiments with fetal glucose tracer infusion (Table III).
The (8, 21, 22) and at delivery achieve levels higher than prelabor values (8, (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Second, fetal values may also rise during normal labor (8, 21, 33) and, at delivery, are usually reported to be higher than simultaneously obtained maternal values (8, (22) (23) (24) (25) (26) (27) (29) (30) (31) (32) (33) (34) (35) . Third, fetal lactate concentrations in both umbilical vessels increase further with elective cesarean section, moderate asphyxia, and severe or fatal asphyxia, demonstrating an enlarging fetal-maternal gradient of lactate concentration (23, 25, 26, 32, (35) (36) (37) . Finally, while umbilical arterial lactate concentrations clearly exceed umbilical venous values during the high levels of lactate typical of asphyxia or distress, this arteriovenous difference narrows and may reverse at the lower fetal lactate concentrations more typical of intrauterine life in the human, sheep or calf (4-5, 8-9, 21-26, 31-38). In combination, these properties demonstrate fetal or cord lactate concentrations to be a sensitive indicator of fetal distress, and support the use of a low scalp pH, elevated lactate level or persistent neonatal lactate acidemia or base deficit as clinically useful measurements of intrapartum distress. Conversely, however, these same properties make it unlikely that lactate measurements from samples obtained at delivery can accurately describe the metabolic profile of the human fetus before labor (37) . Although some authors have concluded that the human fetus uses anaerobic metabolism (6) (7) (8) , others have interpreted their data to indicate that lactate is not normally the end-product of fetal glucose metabolism (39) , and that human fetal metabolism is normally not anaerobic (23) (24) (25) (26) (27) (28) (35) (36) (37) (38) .
This study was undertaken to quantitate the metabolism of lactate within the sheep fetus under chronic steady-state conditions. Previous studies in the fetal sheep have noted higher umbilical venous than fetal arterial lactate concentrations (4, 5) , demonstrating net fetal lactate consumption. These studies have also demonstrated higher uterine venous than maternal arterial lactate concentrations, implicating net placental production of lactate. Our study has extended these findings by quantitating the magnitude of the placental lactate production. The rates of lactate infusion into the uterine and umbilical circulation were measured simultaneously by application of the Fick principle to each circulation. Total placental lactate production measured -12 mg -min-', and supplied the fetus with -2 mg -kg-i min-' of lactate. Thus, lactate is quantitatively second only to glucose as an exogenous fetal nutrient (11) , with infusion rates of individual amino acids much below the rates for glucose or lactate (2) . The LOQ has been used as a measure of fetal lactate uptake, and the present value of 0.21 agrees with previous reports (4, 5) . The fetal lactate uptake measured in this study correlates well with the LOQ (Fig. 2) , confirming the utility of the latter measurement.
It is evident that lactate does not diffuse in net from fetus to mother along the observed fetal-maternal lactate concentration gradient. Instead, the placenta produces lactate that is distributed asymmetrically, with the greater portion transferred to the umbilical circulation with its higher lactate concentration. The processes governing these transfers require further investigation.
Glucose appears the most likely precursor of the uteroplacental lactate production. In agreement with this interpretation, during infusion of tracer glucose to the fetus, we observed higher dpm-lactate-ml-' in the uterine vein than maternal artery and in the umbilical vein than the fetal artery indicating that some uteroplacental lactate production originated from glucose. It should be noted that the production of lactate does not necessarily imply anaerobic metabolism by the uteroplacenta. Glycolysis occurred despite normal oxygen concentrations in the vessels perfusing the uteroplacenta. Placental oxygen consumption of 0.939 mmol. min-' demonstrates a rapid rate of oxidative metabolism occurring concurrently with the lactate production.
The metabolism of lactate was further quantified by the infusion of tracer into the fetus. By measurement of both tracer lactate (dpm-lactate * ml-') and tracee lactate (mg -ml-') in both fetal artery and umbilical vein, several important features were noted. During tracer infusion into the fetus, the tracer lactate concentration in the fetus is experimentally maintained higher than in the mother. Although the metabolism of tracer and tracee lactate are presumed identical, the transfer of tracer and tracee lactate between the fetal, uteroplacental, and maternal compartments may be very different due to the very different concentration relationships observed for tracer and tracee (Fig.  1) . Thus, at the 30:1 tracer concentration gradient from fetus to mother maintained by the fetal tracer lactate infusion, there was a net flux of tracer lactate from the fetus to the placenta. In contrast, the concentration gradient for tracee lactate was -2:1, during which net tracee entered the fetus. Thus, the net flux of tracer did not reflect in magnitude or direction the net flux of tracee. A second finding was that net tracer lactate entering the placenta from the umbilical circulation exceeded the net tracer lactate exit from the placenta to the uterine circulation, indicating placental consumption of tracer. This consumption did not reflect the simultaneously measured net production of tracee lactate. Therefore, in interpretation of fetal tracer studies, tracer and tracee must be considered separately in calculating net tracer and tracee transfer between anatomical compartments, and in calculating net tracer and tracee consumption or production within anatomical compartments. A similar situation exists in tracer glucose infusions into the fetus (11) .
During fetal infusion of tracer lactate, the fetal lactate turnover rate was 6.5±0.8 mg-kg-' min-1, in agreement with other reports (16, 40) . Correcting for net extrafetal irreversible loss of tracer (Eq. 12), this study estimated the fetal lactate utilization rate as 5.9 mg-kg-' min-'. This value is 12% lower than that estimated by Warnes et al. (16) and 25% lower than Prior (40) , both of whom did not correct for extrafetal nonmetabolic loss of tracer from the umbilical circulation.
The interpretation of the LTR has been the subject of considerable discussion. Lactate is rapidly equilibrated with other three-carbon intermediaries, including pyruvate and alanine. In experiments in which lactate is injected as a bolus, a substantial part of the injected label is distributed in pools in reversible equilibrium with the plasma lactate pool, and the apparent turnover rate therefore includes both reversible and irreversible loss of lactate label. Under steady-state conditions, it may be expected that tracer returns from these rapidly reversible pools at a rate approximately equal to the rate of tracer exit from lactate into these pools. For this reason, such reversible losses effectively cancel, and the turnover rate measures only the net of irreversible rates of entry or exit to the plasma lactate pool (47) . We therefore make the assumption that the measured net rate of irreversible loss of lactate tracer infused into the fetus represents fetal irreversible metabolism (40) , which at steady state permits calculation of the total rate of irreversible lactate consumption by the fetus. Under steady-state conditions, the net consumption of lactate by the fetus is equal to the total entry of lactate into the fetus from all endogenous and exogenous (umbilical) sources.
Our study is the first to compare simultaneous measurements of umbilical lactate uptake, representing the exogenous fetal supply of lactate, with fetal lactate utilization, representing net fetal consumption. The difference between the umbilical uptake (1.5 mg. kg-' * min-') and the lactate utilization (6 mg * kg-' -min-') represents the fetal production rate of lactate (Fig. 4) , equal to -4.5 mg -kg-' *min-'.
The substrates from which lactate is produced within the fetus are not entirely known. To address this question, we have used a second tracer technique, tively, the observation that the lactate specific activity during tracer glucose infusion is higher in the fetal artery than vein requires the synthesis of labeled lactate from tracer glucose within the fetus. Quantitatively, we have derived two estimators of the magnitude of the conversion of glucose to lactate. The first, LPRGin estimates the minimal amount of glucose that must be converted to lactate in order to account for the observed glucose and lactate specific activities.
This minimum conversion was 1-1.5 mg * kg-l* min-', requiring therefore that the total fetal lactate consumption must exceed the net exogenous umbilical lactate entry. The second estimator, LPRG, is the actual rate of lactate conversion from glucose, and additionally requires independent estimation of the total lactate utilization rate within the fetus. Using two methods of estimation of fetal lactate utilization, we have estimated that the fetal production rate of lactate from glucose was -3 mg * kg-' -min-', or -50% of the fetal lactate utilization rate. These analyses demonstrate that glucose is not the sole precursor of lactate within the fetus.
Considering possible metabolic fates of lactate within the fetus, the maintenance of a stable fetal lactate con- (41) transfer into and from the fetus may be more rapid, although experimental differences preclude direct comparison of rates as well as whether simple or facilitated diffusion governs the transfer (41) .
Although glucose is generally considered obligatory for fetal brain metabolism, there is no known obligatory requirement for lactate by any organ. Only fetal heart (42) and portal drained viscera (43) have been shown to consume lactate in the chronically catheterized fetal lamb. Calculated from the published values of lactate consumption, these organs could consume about 0.15 and 0.20 mg * kg-', substantially below either umbilical lactate uptake or fetal lactate utilization demonstrated in the present studies. Liver and kidney appear to be the largest consumers of lactate in the adult (20) , although net lactate consumption by these organs has not been reported in the fetal sheep.
This study confirms that lactate is an important exogenous nutrient for the fetal sheep, and defines metabolic relationships between lactate, glucose, and nonglucose fetal nutrients. A similar role for lactate in fetal metabolism may be present in other species. Fetal lactate uptake has been measured in the chronically catheterized fetal calf (9) , and appears to be of even larger magnitude than for the sheep. Acute studies in several species have demonstrated umbilical venousfetal arterial lactate concentration relationships compatible with net fetal lactate consumption (34 Application of turnover methodology to the fetus. The mother, fetus, and placenta represent interconnected, anatomically definable regions. To estimate the portion of irreversible lactate loss that occurs within the anatomic fetus, it is necessary to exclude that portion of the tracer which is irreversibly lost to the placenta via the umbilical circulation (11) . The dpm-lactate leaving the fetus via the umbilical artery may be calculated as the product of the dpmlactate ml-' measured in the umbilical artery times the umbilical blood flow (Eq. 10). Similarly, the dpm-lactate entering the fetus via the umbilical vein may be calculated as the product of the dpm-lactate' ml-' in the umbilical vein times the umbilical blood flow (Eq. 9). The difference between Eqs. 9 and 10 represents the net rate of extrafetal loss of lactate during fetal lactate infusion (Eq. 11). The difference between the net rate of extrafetal tracer loss, and the total fetal rate of infusion represents the actual rate of irreversible loss of tracer within the anatomic fetus (Eq. 12). This value divided by the lactate specific activity in the umbilical artery (Eq. 13), defines an estimate of the actual net lactate utilization rate (LUR) occurring within the anatomic fetus. This figure represents the amount of tracee lactate (mg-min-') required to be irreversibly lost within the anatomic fetus in order to account for the known fetal irreversible loss of tracer (Eq. 12) at the measured fetal lactate specific activity (L).
The choice of Ls specifies that this is the apparent fetal irreversible loss of tracee from the viewpoint of an observer located in the umbilical artery. At steady state, the umbilical circulation acts as a source of tracee lactate and a sink of tracer lactate, so that the specific activities in the umbilical artery and umbilical vein are each constant with time but are maintained at different absolute levels. Both the LTR and the LUR in the fetus must therefore be specified in terms of the site of sampling. From a practical standpoint, the measured differences of Ls and Ls are very small, and the LUR and LTR measured at either the umbilical vein or umbilical artery will yield very similar results. We have arbitrarily chosen the LQ for computation of Eqs. 13 and 14.
Consideration of the error in determining steady state. The foregoing has assumed a system at a mathematically defined steady state, such that the concentrations of tracer and tracee remain constant at the sampling site, and that all reversibly-connected subsystems have fully equilibrated. Under these conditions, the LTR and LUR calculated by the above equations estimate the net irreversible loss of tracee from the total system, and from the anatomic fetus, as seen by an observer at the sampling site. In real experiments, it is unlikely either that the steady state can be proven with certainty, or that all reversibly connected regions have fully equilibrated within the relatively short time of lactate infusion.
If one considers a simplified system in which the actual LC, LTR, and LUR are constant and in which the fetus is infused with an unprimed constant infusion of an ideal tracer L°distributed in a volume Vd, one can define the potential error in estimation of LTR due to the possibility of nonachievement of steady state. If at experimentally chosen "steady state", a change in specific activity of "C" percent 190 J. W. Sparks, W. W. Hay, Jr., D. Bonds, G. Meschia, and F. C. Battaglia per minute cannot be excluded statistically by the actual data, then the dpm/minute (R) that could contribute to such a rise may be expressed: R = (C)(Ls)(Lc)(Vd)/100 (A3). Thus, the corrected rate of tracer lactate infusion partitioned to irreversible pathways is given by: R,L corr = R,L -R (A4).
lUsing values of C = 5% /75 min, Vd = 600 ml * kg-' (16) , fetal weight = 4 kg, a measured LUR of 6 mg * kg-' * min-', and typical values of R1L and Ls from the present studies, then the permitted confidence limit for estimation of LUR would be-±1%. Restated, the presence of unequilibrated pools reversibly connected to the blood lactate pool would permit an error of as large as ±1%.
Observations during fetal infusion of tracer glucose
Conceptually, the specific activity of lactate at steady state may be considered as the ratio of the infusion rate of tracer lactate to the infusion rate of tracee lactate (Eq. 15). During infusion of tracer glucose into the fetus, this relationship permits calculation of the rate of lactate production from glucose and nonglucose substrates. The exogenous rate of tracer lactate infusion into the anatomic fetus equals the measured umbilical blood flow (Qf) times the measured umbilical venous-arterial difference in dpm-lactate (Eq. 11). Similarly, the rate of endogenous production of dpm-lactate from glucose during infusion of labeled glucose can be taken as the product of the measured glucose specific activity (CSAa) times the rate of conversion of glucose to lactate occurring within the anatomic fetus (defined as LPR0). The total rate of entry of dpm-lactate is the sum of the endogenous production and exogenous entry rates (Eq. 16). By similar reasoning, the total infusion rate of unlabeled lactate into the anatomic fetus may be considered as the sum of the lactate umbilical uptake (Eq. 1) plus the endogenous fetal lactate production from glucose (LPRG) and nonglucose (LPRNG) substrates (Eq. 17). The lactate specific activity at steady state is given as the ratio of Eq. 16 to Eq. 17, from which can be derived the relationships shown in Eqs. 18, 19, and 20 . In these equations, the term LPRGin represents the minimum production of lactate from glucose occurring within the anatomic fetus that is required to account for the observed concentrations of labeled and unlabeled lactate in the umbilical vein and artery. The actual LPRG may exceed this minimum value, and the proportion of this excess production of lactate derived from glucose and nonglucose sources is defined by the constant KI. If the total rate of lactate utilization within the anatomic fetus (LUR) is also known, then the actual values of LPRG and LPRNG can be determined from Eqs. 17 and 20.
